Concepedia

Alaaeldin Shablak

AS

Statistics

Publications

9

Citations

304

H-Index

9

Active since

2007

Affiliations

University of Manchester(Current)

The Christie NHS Foundation Trust

University of Glasgow

Bradford Royal Infirmary

Amsterdam University Medical Centers

Alaaeldin Shablak is an author at University of Manchester specializing in medicine, oncology, and immunotherapy.

Publications per year

2007–2020

9

Publications

9

Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma

Alma Moekotte, Sanne Lof, Stijn van Roessel et al. · Annals of Surgery · 2019 · 67 citations · Full text

, , +16

Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study

Alma Moekotte, Giuseppe Malleo, Stijn van Roessel et al. · British journal of surgery · 2020 · 63 citations

, , +15

Vaccination of Patients With Metastatic Renal Cancer With Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Interferon-α

Robert E. Hawkins, Catriona Macdermott, Alaaeldin Shablak et al. · Journal of Immunotherapy · 2009 · 43 citations

, , +17

Adoptive transfer of Treg depleted autologous T cells in advanced renal cell carcinoma

Fiona Thistlethwaite, Eyad Elkord, Richard W. Griffiths et al. · Cancer Immunology Immunotherapy · 2007 · 34 citations · Full text

, , +14

High-dose Interleukin-2 Can Produce a High Rate of Response and Durable Remissions in Appropriately Selected Patients With Metastatic Renal Cancer

Alaaeldin Shablak, Kanwal A. Sikand, Jonathan H. Shanks et al. · Journal of Immunotherapy · 2010 · 34 citations

, , +15

1–5 of 9